121679-20-7,
3,4-Didehydronaratriptan,
3,4-Dihydro Naratriptan (Naratriptan Impurity B),
UNII-YCR9MR124U,
YCR9MR124U,
N-Methyl-3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indole-5-ethanesulfonamide,
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-,
3,4-Didehydro naratriptan,
Naratriptan Impurity B,
3,4-Dihydro Naratriptan,
USP naratriptan related compound B free base,
SCHEMBL1275552,
CTK8E8529,
DTXSID30153336,
UJPMSESNMYEKDD-UHFFFAOYSA-N,
ZINC35644084,
2-(3-(1-Methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-5-yl)ethanesulfonic acid methylamide,
Naratriptan hydrochloride impurity, 2-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-5-yl)ethanesulfonic acid methylamide- [USP],
DB-061950,
RT-008196,
FT-0666991,
J-004583,
2-[3-(1-methyl-1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indol-5-yl]-ethanesulfonic acid methylamide,